CAPRICOR THERAPEUTICS, INC. Current Liabilities
CAPRICOR THERAPEUTICS, INC. (CAPR) had Current Liabilities of $32.96 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $32.96M.
- 2026-03-31: Liabilities, Current $33.64M.
- 2025-12-31: Liabilities, Current $35.84M.
- 2025-09-30: Liabilities, Current $28.15M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $32.96M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $33.64M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $35.84M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $28.15M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $28.40M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $22.34M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $21.03M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $20.48M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $22.35M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $26.38M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $31.27M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $32.93M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $35.15M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $37.13M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $23.59M 10-K · filed 2024-03-11 | |
| 2022-09-30 | $23.19M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $19.55M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $14.32M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $4.13M 10-K · filed 2023-03-17 | |
| 2021-09-30 | $2.99M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $3.17M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $3.75M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $2.97M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $2.28M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $1.92M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.32M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $897.99K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $960.72K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.57M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.50M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.26M 10-K · filed 2020-03-27 | |
| 2018-09-30 | $1.88M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $1.32M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $1.48M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $1.67M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $16.69M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $16.64M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $3.30M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.90M 10-K · filed 2018-03-22 | |
| 2016-09-30 | $6.67M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $6.20M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $7.34M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $6.53M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $6.53M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $6.86M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $7.55M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $6.30M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $6.19M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $6.49M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $6.30M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $2.05M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $1.18M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $1.02M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $649.13K 10-Q · filed 2013-06-21 | |
| 2012-12-31 | $529.17K 10-K · filed 2014-03-31 | $330.98K 10-K · filed 2013-06-21 |
| 2012-09-30 | $287.14K 10-Q · filed 2013-06-21 | |
| 2012-06-30 | $267.06K 10-Q/A · filed 2012-09-10 | |
| 2012-03-31 | $485.35K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $541.45K 10-Q · filed 2013-06-21 | |
| 2011-09-30 | $717.82K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $436.27K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $1.07M 10-K · filed 2012-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |